Laboratorios Atral
Private Company
Funding information not available
Overview
Laboratorios Atral is an established, private Portuguese pharmaceutical firm with a dual business model encompassing proprietary product commercialization and contract services. The company has a historical legacy in antibiotic production and now maintains a portfolio of branded generic and specialty medicines, primarily in ophthalmology and dermatology. Its strategic focus includes expanding its service offerings as a CDMO and leveraging its regulatory expertise to commercialize products across Europe, Latin America, the Middle East, and Africa. Atral's operations are underpinned by a full-spectrum in-house infrastructure covering R&D, production, quality control, and pharmacovigilance.
Technology Platform
Integrated pharmaceutical development and manufacturing service platform, including GMP production, regulatory affairs, pharmacovigilance, and quality control for solid and semi-solid dosage forms.
Opportunities
Risk Factors
Competitive Landscape
In proprietary products, Atral competes with other generic and specialty pharma companies in Portugal and internationally. In CDMO services, it competes with a range of organizations from large global CDMOs to smaller regional manufacturers, differentiating itself through full-service integration and specific regulatory market expertise.